Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101-Reference-Cited by-同舟云学术

Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101

Published:2017-04 Issue: Volume:55 Page:41-48
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Chien Wei Wen,Niogret Charlène,Jugé Romain,Lionnard Loïc,Cornut-Thibaut Aurélie,Kucharczak Jérôme,Savina Ariel,Salles Gilles,Aouacheria Abdel

Funder

Roche Pharma, La Ligue Contre le Cancer (Comité de la Loire)

Institut Carnot CALYM

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference51 articles.

1. Mechanisms of killing by anti-CD20 monoclonal antibodies;Glennie;Mol. Immunol.,2007

2. Anti-CD20 monoclonal antibodies: historical and future perspectives;Lim;Haematologica,2010

3. CD20-targeted therapy: the next generation of antibodies;van Meerten;Semin. Hematol.,2010

4. Rituximab resistance;Rezvani;Best Pract. Res. Clin. Haematol.,2011

5. Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties;Klein;mAbs,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia;Cancers;2021-06-21

2. The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia;Frontiers in Immunology;2021-02-11

3. Oxidative damage of lysosomes in regulated cell death systems: Pathophysiology and pharmacologic interventions;Free Radical Biology and Medicine;2020-09

4. Discovery and Development of Obinutuzumab (GAZYVA, GAZYVARO), a Glycoengineered Type II Anti-CD20 Antibody for the Treatment of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia;Successful Drug Discovery;2018-04-16

5. Direct targeting of cancer cells with antibodies: What can we learn from the successes and failure of unconjugated antibodies for lymphoid neoplasias?;Journal of Autoimmunity;2017-12